e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Clinical studies in lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Heterogeneity within chronic lung allograft dysfunction: A BAL analysis
S. Verleden, D. Ruttens, E. Vandermeulen, D. Van Raemdonck, R. Vos, B. Vanaudenaerde, G. Verleden (Leuven, Belgium)
Source:
Annual Congress 2013 –Clinical studies in lung transplantation
Session:
Clinical studies in lung transplantation
Session type:
Thematic Poster Session
Number:
2682
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Verleden, D. Ruttens, E. Vandermeulen, D. Van Raemdonck, R. Vos, B. Vanaudenaerde, G. Verleden (Leuven, Belgium). Heterogeneity within chronic lung allograft dysfunction: A BAL analysis. Eur Respir J 2013; 42: Suppl. 57, 2682
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Definition and history of sarcoidosis
The impact of anti-IgE treatment on the airway microbiome in asthma.
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Related content which might interest you:
Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Eosinophilia predicts poor outcome after lung transplantation
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013
Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Immediate post-operative bronchoalveolar neutrophilia is associated with FEV
1
early after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014
Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011
BAL neutrophilia increases mortality in lung transplant patients despite azithromycin treatment
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013
Posaconazole levels in the bronchoalveolar lavage from lung transplant recipients
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Utility of bronchoalveolar lavage in vasculitis patients
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Utility of bronchoalveolar lavage in the determination of lung asbestos burden in Barcelona, Spain
Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Year: 2013
Importance of early bronchoalveolar lavage in immunocompromised patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept